Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Debt to Equity (2016 - 2025)

Mimedx's Debt to Equity history spans 11 years, with the latest figure at $0.07 for Q4 2025.

  • For Q4 2025, Debt to Equity fell 28.18% year-over-year to $0.07; the TTM value through Dec 2025 reached $0.07, down 28.18%, while the annual FY2025 figure was $0.07, 28.18% down from the prior year.
  • Debt to Equity for Q4 2025 was $0.07 at Mimedx, down from $0.08 in the prior quarter.
  • Across five years, Debt to Equity topped out at $586.91 in Q4 2021 and bottomed at -$8.27 in Q3 2021.
  • The 5-year median for Debt to Equity is $0.07 (2025), against an average of $29.11.
  • The largest annual shift saw Debt to Equity crashed 375.47% in 2021 before it soared 1582.54% in 2023.
  • A 5-year view of Debt to Equity shows it stood at $586.91 in 2021, then plummeted by 100.46% to -$2.7 in 2022, then soared by 112.73% to $0.34 in 2023, then tumbled by 71.66% to $0.1 in 2024, then decreased by 28.18% to $0.07 in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Debt to Equity are $0.07 (Q4 2025), $0.08 (Q3 2025), and $0.09 (Q2 2025).